PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH
Cvetka Bačar Bole
; Psychiatric Hospital Idrija, Idrija, Slovenia
Mitja Pišlar
; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Aleš Mrhar
; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
Rok Tavčar
; University Psychiatric Clinic Ljubljana, Ljubljana, Slovenia
APA 6th Edition Bačar Bole, C., Pišlar, M., Mrhar, A. i Tavčar, R. (2017). PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH. Psychiatria Danubina, 29 (2), 155-161. https://doi.org/10.24869/psyd.2017.155
MLA 8th Edition Bačar Bole, Cvetka, et al. "PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH." Psychiatria Danubina, vol. 29, br. 2, 2017, str. 155-161. https://doi.org/10.24869/psyd.2017.155. Citirano 16.01.2021.
Chicago 17th Edition Bačar Bole, Cvetka, Mitja Pišlar, Aleš Mrhar i Rok Tavčar. "PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH." Psychiatria Danubina 29, br. 2 (2017): 155-161. https://doi.org/10.24869/psyd.2017.155
Harvard Bačar Bole, C., et al. (2017). 'PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH', Psychiatria Danubina, 29(2), str. 155-161. https://doi.org/10.24869/psyd.2017.155
Vancouver Bačar Bole C, Pišlar M, Mrhar A, Tavčar R. PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH. Psychiatria Danubina [Internet]. 2017 [pristupljeno 16.01.2021.];29(2):155-161. https://doi.org/10.24869/psyd.2017.155
IEEE C. Bačar Bole, M. Pišlar, A. Mrhar i R. Tavčar, "PRESCRIBING PATTERNS FOR INPATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS IN A PSYCHIATRIC HOSPITAL IN SLOVENIA: RESULTS OF 16-MONTH PROSPECTIVE, NON-INTERVENTIONAL CLINICAL RESEARCH", Psychiatria Danubina, vol.29, br. 2, str. 155-161, 2017. [Online]. https://doi.org/10.24869/psyd.2017.155
Sažetak Background: In Slovenia, there has been no evidence about the prescribing patterns for inpatients with psychotic disorders. The
research aims to analyze drug utilization patterns for inpatients with psychotic disorder that are coded as F20-F29 according to
International Classification of Diseases (ICD) 10th revision (schizophrenia spectrum disorders).
Subjects and methods: Prospective research was conducted at the Psychiatric Hospital Idrija. The medical records of the
inpatients admitted over a 12-month period were collected from the beginning to the end of their hospitalization.
Results: A total of 311 inpatients with 446 hospitalizations were included, producing a total of 3954 medication prescriptions.
Medications prescribed pro re nata (the use of as needed) were also taken into account. Antipsychotics (N=1149, 43% of prescriptions)
were the most often prescribed medications, followed by anxiolytics, antiparkinsonians, antidepressants, mood stabilizers and
cardiovascular drugs. A total of 256 (82%) inpatients received at least one pro re nata medication. It was observed that the studied
population was treated with one antipsychotic on 27 percent of prescriptions.
Conclusions: Inpatients with schizophrenia spectrum disorders were exposed to a large number of different drugs. They were not
received only psychotropic drugs but also other medications. With the knowledge about medications the implementation of clinical
pharmacy services to the psychiatrists would significantly improve medication of inpatients with psychotic disorders and
polypharmacotherapy.